DJ-1 as a potential biomarker for the early diagnosis in lung cancer patients

DJ-1 is a novel oncogene that can transform NIH3T3 cells in cooperation with the activated ras gene. DJ-1 appears to have its greatest effect on tumourigenesis, and it may have a greater impact on early-stage lung cancers. In this study, we proposed to investigate the clinical value of DJ-1 protein...

Full description

Saved in:
Bibliographic Details
Main Authors: Binbin Han, Jiwen Wang, Jia Gao, Shana Feng, Yu Zhu, Xuexiang Li, Ting Xiao, Jun Qi, Wei Cui
Format: Article
Language:English
Published: SAGE Publishing 2017-06-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317714625
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850057070075707392
author Binbin Han
Jiwen Wang
Jia Gao
Shana Feng
Yu Zhu
Xuexiang Li
Ting Xiao
Jun Qi
Wei Cui
author_facet Binbin Han
Jiwen Wang
Jia Gao
Shana Feng
Yu Zhu
Xuexiang Li
Ting Xiao
Jun Qi
Wei Cui
author_sort Binbin Han
collection DOAJ
description DJ-1 is a novel oncogene that can transform NIH3T3 cells in cooperation with the activated ras gene. DJ-1 appears to have its greatest effect on tumourigenesis, and it may have a greater impact on early-stage lung cancers. In this study, we proposed to investigate the clinical value of DJ-1 protein in the early diagnosis of lung cancer and compared its diagnostic value with other biomarkers. Preoperative serum DJ-1 levels were measured in 300 lung cancer patients and compared with benign pulmonary disease (n = 44) and healthy volunteers (n = 64). Using tissue microarrays and immunohistochemical analyses, we compared the DJ-1 expression between the primary squamous cell carcinoma tumours and matched metastatic tissues from a lymph node. The baseline preoperative serum DJ-1 of lung cancer patients was significantly higher than that of benign diseases and healthy controls (p < 0.001). In the early-stage subgroup, the median DJ-1 concentration (ng/mL) was significantly higher than that of the advanced stage (12.90 vs 7.75, p < 0.05). Using immunohistochemistry, we observed that the DJ-1 staining intensity was generally weaker and less common in the metastatic tissues compared with that in the primary tumour (McNemar–Bowker Test, p = 0.008). DJ-1 was highly expressed in the early stage of lung cancer, and its expression was significantly decreased after metastasis. Therefore, DJ-1 may be a potential biomarker for the early diagnosis and monitoring of lung cancer metastasis.
format Article
id doaj-art-5ffd93afb02c49baae80ad28280107f4
institution DOAJ
issn 1423-0380
language English
publishDate 2017-06-01
publisher SAGE Publishing
record_format Article
series Tumor Biology
spelling doaj-art-5ffd93afb02c49baae80ad28280107f42025-08-20T02:51:31ZengSAGE PublishingTumor Biology1423-03802017-06-013910.1177/1010428317714625DJ-1 as a potential biomarker for the early diagnosis in lung cancer patientsBinbin Han0Jiwen Wang1Jia Gao2Shana Feng3Yu Zhu4Xuexiang Li5Ting Xiao6Jun Qi7Wei Cui8Department of Clinical Laboratory, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, ChinaDepartment of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou, ChinaDepartment of Clinical Laboratory, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, ChinaDepartment of Clinical Laboratory, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, ChinaDepartment of Clinical Laboratory, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, ChinaDepartment of Clinical Laboratory, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, ChinaState Key Laboratory of Molecular Oncology, Department of Etiology and Carcinogenesis, National Cancer Center/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Clinical Laboratory, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, ChinaDepartment of Clinical Laboratory, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, ChinaDJ-1 is a novel oncogene that can transform NIH3T3 cells in cooperation with the activated ras gene. DJ-1 appears to have its greatest effect on tumourigenesis, and it may have a greater impact on early-stage lung cancers. In this study, we proposed to investigate the clinical value of DJ-1 protein in the early diagnosis of lung cancer and compared its diagnostic value with other biomarkers. Preoperative serum DJ-1 levels were measured in 300 lung cancer patients and compared with benign pulmonary disease (n = 44) and healthy volunteers (n = 64). Using tissue microarrays and immunohistochemical analyses, we compared the DJ-1 expression between the primary squamous cell carcinoma tumours and matched metastatic tissues from a lymph node. The baseline preoperative serum DJ-1 of lung cancer patients was significantly higher than that of benign diseases and healthy controls (p < 0.001). In the early-stage subgroup, the median DJ-1 concentration (ng/mL) was significantly higher than that of the advanced stage (12.90 vs 7.75, p < 0.05). Using immunohistochemistry, we observed that the DJ-1 staining intensity was generally weaker and less common in the metastatic tissues compared with that in the primary tumour (McNemar–Bowker Test, p = 0.008). DJ-1 was highly expressed in the early stage of lung cancer, and its expression was significantly decreased after metastasis. Therefore, DJ-1 may be a potential biomarker for the early diagnosis and monitoring of lung cancer metastasis.https://doi.org/10.1177/1010428317714625
spellingShingle Binbin Han
Jiwen Wang
Jia Gao
Shana Feng
Yu Zhu
Xuexiang Li
Ting Xiao
Jun Qi
Wei Cui
DJ-1 as a potential biomarker for the early diagnosis in lung cancer patients
Tumor Biology
title DJ-1 as a potential biomarker for the early diagnosis in lung cancer patients
title_full DJ-1 as a potential biomarker for the early diagnosis in lung cancer patients
title_fullStr DJ-1 as a potential biomarker for the early diagnosis in lung cancer patients
title_full_unstemmed DJ-1 as a potential biomarker for the early diagnosis in lung cancer patients
title_short DJ-1 as a potential biomarker for the early diagnosis in lung cancer patients
title_sort dj 1 as a potential biomarker for the early diagnosis in lung cancer patients
url https://doi.org/10.1177/1010428317714625
work_keys_str_mv AT binbinhan dj1asapotentialbiomarkerfortheearlydiagnosisinlungcancerpatients
AT jiwenwang dj1asapotentialbiomarkerfortheearlydiagnosisinlungcancerpatients
AT jiagao dj1asapotentialbiomarkerfortheearlydiagnosisinlungcancerpatients
AT shanafeng dj1asapotentialbiomarkerfortheearlydiagnosisinlungcancerpatients
AT yuzhu dj1asapotentialbiomarkerfortheearlydiagnosisinlungcancerpatients
AT xuexiangli dj1asapotentialbiomarkerfortheearlydiagnosisinlungcancerpatients
AT tingxiao dj1asapotentialbiomarkerfortheearlydiagnosisinlungcancerpatients
AT junqi dj1asapotentialbiomarkerfortheearlydiagnosisinlungcancerpatients
AT weicui dj1asapotentialbiomarkerfortheearlydiagnosisinlungcancerpatients